Affinivax has a total of 39 patents globally, out of which 16 have been granted. Of these 39 patents, more than 94% patents are active. United States of America is where Affinivax has filed the maximum number of patents, followed by Australia and Singapore. Parallelly, United States of America seems to be the main focused R&D centre of Affinivax.
Affinivax was founded in the year 2014 by Fan Zhang, George Siber, Richard Malley and Yingjie Lu. Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Do read about some of the most popular patents of Affinivax which have been covered by us in this article and also you can find Affinivax patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Affinivax patent portfolio.
How many patents does Affinivax have?
Affinivax has a total of 39 patents globally. These patents belong to 5 unique patent families. Out of 39 patents, 37 patents are active.
How Many Patents did Affinivax File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Affinivax Applications Filed | Affinivax Patents Granted |
| 2022 | – | 4 |
| 2021 | 10 | 12 |
| 2020 | 3 | – |
| 2019 | 14 | – |
| 2018 | 12 | – |
How many Affinivax patents are Alive/Dead?
How Many Patents did Affinivax File in Different Countries?
Countries in which Affinivax File patents
| Countries | Patents |
| United States Of America | 3 |
| Australia | 2 |
| Singapore | 2 |
| Malaysia | 2 |
| Canada | 2 |
| Viet Nam | 2 |
| China | 2 |
| Israel | 2 |
| Colombia | 2 |
| Philippines | 2 |
| Europe | 2 |
| Brazil | 2 |
| South Africa | 2 |
| Hong Kong (S.A.R.) | 2 |
| India | 2 |
| Indonesia | 2 |
| Mexico | 1 |
| Chile | 1 |
| Peru | 1 |
| Taiwan | 1 |
Where are Research Centres of Affinivax Patents Located?
List of Affinivax Patents
| Affinivax Patents | Title |
| BR112019027387A8 | IMMUNOGENIC compositions |
| EP3849587A4 | Multivalent pneumococcal vaccines |
| US20220072118A1 | Immunogenic compositions |
| PH12021550542A1 | Multivalent pneumococcal vaccines |
| VN82546A | Pneumococcal Vaccination Pneumococcal VARIOUS, Immune Complex, Containing BIOTINYLIED POLYSACARIATE ANTI, PHARMACEUTICAL AND PHARMACEUTICAL CONTAINS AND METHODS FOR CREATION |
| HK40046980A | Multivalent pneumococcal vaccines |
| US20210346487A1 | Multivalent pneumococcal vaccines |
| IN202117016515A | Multivalent pneumococcal vaccines |
| CL202100608A1 | multivalent pneumococcal vaccines |
| ID2021PID07790A | Multivalent pneumococcal vaccine |
| MX2021002910A | MULTIVALENT PNEUMOCOCCAL VACCINES |
| CO20210004456A2 | multivalent pneumococcal vaccines |
| PE0011122021A1 | MULTIVALENT PNEUMOCOCCAL VACCINES |
| CN112969474A | Multivalent pneumococcal vaccines |
| BR112021004193A2 | MULTIVALENT Pneumococcal vaccines |
| US11013793B2 | Multivalent pneumococcal vaccines |
| AU2019338473A1 | Multivalent pneumococcal vaccines |
| IL281204A | Multivalent pneumococcal vaccines |
| ZA202101470A | Multivalent pneumococcal vaccines |
| SG11202102007UA | Multivalent pneumococcal vaccines |
| VN74087A | Immune-Stimulating PHARMACEUTICAL PRODUCTS AND PHARMACEUTICAL CONTAINS |
| HK40021266A | Immunogenic compositions |
| PH12019502915A1 | Immunogenic compositions |
| ID2020PID02559A | IMUNOGENIC COMPOSITION |
| TW202019470A | Multivalent pneumococcal vaccines |
| EP3641828A1 | Immunogenic compositions |
| CN111065417A | Immunogenic compositions |
| CO20190014647A2 | immunogenic compositions |
| WO2020056202A1 | Multivalent pneumococcal vaccines |
| CA3111459A1 | Multivalent pneumococcal vaccines |
| MYPI2021001244A0 | Multivalent pneumococcal vaccines |
| AU2018290298A2 | Immunogenic compositions |
| IN202047002529A | Immunogenic compositions |
| IL271603A | Immunogenic compositions |
| SG11201912601RA | Immunogenic compositions |
| ZA201908498A | Immunogenic compositions |
| WO2018237221A1 | Immunogenic compositions |
| CA3067587A1 | Immunogenic compositions |
| MYPI2019007645A0 | Immunogenic compositions |